首页   按字顺浏览 期刊浏览 卷期浏览 Cellular selectivity of aldosterone action: role of 11 beta-hydroxysteroid dehydr...
Cellular selectivity of aldosterone action: role of 11 beta-hydroxysteroid dehydrogenase

 

作者: Rafn Benediktsson,   Brian Walker,   Christopher Edwards,  

 

期刊: Current Opinion in Nephrology and Hypertension  (OVID Available online 1995)
卷期: Volume 4, issue 1  

页码: 41-46

 

ISSN:1062-4821

 

年代: 1995

 

出版商: OVID

 

数据来源: OVID

 

摘要:

Mineralocorticoid receptors in the distal nephron have no intrinsic specificity for mineralocorticoids over glucocorticoids (cortisol in humans; corticosterone in rodents), but are protected from glucocorticoids by the enzyme 11β-hydroxysteroid dehydrogenase, which inactivates these steroids to cortisone and 11-dehydrocorticosterone, respectively. Recent work has demonstrated that the enzyme is expressed as multiple tissue-specific isoforms, some of which catalyse the reverse conversion of cortisone to cortisol. These isoforms may allow 11β-hydroxysteroid dehydrogenase to modulate access of ligands to glucocorticoid and mineralocorticoid receptors, as well as to amplify and attenuate tissue responses. 11β-hydroxysteroid dehydrogenase-mediated protection of mineralocorticoid receptors fails in congenital 11 β-hydroxysteroid dehydrogenase deficiency and after inhibition of the enzyme by liquorice. In these circumstances, cortisol-dependent mineralocorticoid excess and hypertension ensue. Recent studies suggest that similar deficiencies of 11β-dehydrogenase activity may contribute to pathophysiology in common clinical syndromes, illustrating the potential significance of this novel mechanism for development of hypertension.

 

点击下载:  PDF (584KB)



返 回